OSKARE CAPITAL
OSKARE CAPITAL
Industry:
Agriculture Cannabis Life Science Medical Venture Capital
Founded:
2020-06-19
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Global Site Tag
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Medical Cannabis Payment Solutions
MCPS's leadership team manages the world's most technologically advanced medical cannabis company
Truehitt 1
Truehitt is a recreational cannabis producer.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-10-26 | Herbolea Biotech | Oskare Capital investment in Series A - Herbolea Biotech | 5 M EUR |
| 2021-03-11 | Octarine Bio | Oskare Capital investment in Seed Round - Octarine Bio | 1.2 M USD |
| 2020-11-12 | Octarine Bio | Oskare Capital investment in Seed Round - Octarine Bio | 1.8 M USD |
| 2020-01-13 | Octarine Bio | Oskare Capital investment in Pre Seed Round - Octarine Bio | N/A |
More informations about "Oskare Capital"
Óskare Capital - LinkedIn
Óskare Capital | 1,503 followers on LinkedIn. Headquartered in Paris and London, Óskare Capital specializes in venture-stage investments in the Deeptech and Life Sciences sectors.See details»
Oskare Capital - Crunchbase Investor Profile
Oskare Capital is a venture capital firm. Lists Featuring This Company. Edit Lists Featuring This Company Section. Ile-de-France Investors . 1,365 Number of Organizations • $75.2B Total Funding Amount • 719 Number of Investors. …See details»
Óskare Capital - The Org
Headquartered in Paris and London, Óskare Capital specializes in venture-stage investments in the Deeptech and Life Sciences sectors. Industries. Life Sciences, Venture Capital. …See details»
Oskare Capital and its vital role in the pharma industry
The European market now has a significant need for early-stage capital to cement the foundations of the new sector and support its rapid growth rate. FUND ORIGINS In light of this, Oskare …See details»
Óskare Capital investment portfolio - PitchBook
Founded in 2020, Oskare Capital is a venture capital firm based in Paris, France. The firm specializes in early-stage investments operating in the deep-tech and life sciences sectors. …See details»
Oskare Capital - Investments, Portfolio & Company Exits
Oskare Capital has made 7 investments. Their most recent investment was on Nov 8, 2023, when Octarine Bio raised. obfuscated. obfuscated. How many investments has this organization …See details»
Oskare Capital SAS - Company Profile and News - Bloomberg …
Oskare Capital SAS is an investment company. The Company specializes in venture-stage investments in the deeptech and life sciences sectors. Oskare Capital operates in France and …See details»
Oskare Capital - Investor Profile, Portfolio & Team - Tracxn
Jan 29, 2025 Co-investors of Oskare Capital. Over the past . 5 years, 7 investors have co-invested in Oskare Capital's portfolio companies.. This includes funds and angels.Invested …See details»
Oskare Capital Investor Information - Funding, Portfolio …
Oskare Capital is a venture capital fund with offices in Paris and London. It focuses on Series A investments in biotech, manufacturing, health tech, and pharma, providing funding between …See details»
Oskare Capital - Contacts, Employees, Board Members
Oskare Capital has 3 current employee profiles, including Venture Partner Jeff Wechsler. Contacts. Edit Contacts Section. Job Department. Protected Content. Business Management. …See details»
Cannabis-Focused ÓSkare Capital Is Raising a $170 Million Fund ...
Feb 17, 2022 Óskare Capital, a Paris-based venture firm with the backing of industry heavyweights, is raising a 150-million-euro fund (about $171 million) to chase down deals in …See details»
Oskare Capital and its vital role in the pharma industry - Licorne Gulf
Jun 20, 2022 In light of this, Oskare Capital launched the first regulated fund to help foster this extremely exciting new sector and capitalize on the wealth of opportunity. The team, like so …See details»
Oskare Capital - EU-Startups
Oskare Capital. Oskare Capital. Headquartered in Paris and London, Óskare Capital specializes in venture-stage investments in the Deeptech and Life Sciences sectors. Investor Type: VC …See details»
Oskare Capital - Portfolio, Partners, Reviews, News
Based in Paris (France), ÓSKARE CAPITAL is advising Dublin based Oskare Fund I, an AIFMD regulated ICAV. Óskare Fund I started its operations in Q3, 2022. This pioneer investment …See details»
ABO - Óskare Capital: Partnership Announcement - Business Wire
Jan 26, 2022 Alpha Blue Ocean (ABO) and Óskare Capital are announcing today the formation of a strategic partnership. ABO - Óskare Capital: Partnership Announcement January 26, 2022 …See details»
Oskare Capital - Updates, News, Events, Signals & Triggers
Headquartered in Paris and London, Óskare Capital specializes in venture-stage investments in the Deeptech and Life Sciences sectors.See details»
Oskare Capital - CB Insights
Oskare Capital focuses on innovative companies and teams in the medical cannabinoid industry. Use the CB Insights Platform to explore Oskare Capital's full profile. Oskare Capital Portfolio …See details»
Oskare Capital and Sapphire Capital Partners LLP Launch First Ever …
Dec 1, 2021 Oskare Capital on Instagram; Contacts. PRESS CONTACTS: Katy Horrocks Tel: 07725 218 579 Email: [email protected]. Oliver Lamb Tel: 07900 904 532 Email: …See details»
OSKARE CAPITAL UK, LTD overview - Companies House
Filing history for OSKARE CAPITAL UK, LTD (13494090) People for OSKARE CAPITAL UK, LTD (13494090) More for OSKARE CAPITAL UK, LTD (13494090) Registered office address 14 …See details»
Eric Trump announces lawsuit against Capital One over alleged de ...
Mar 7, 2025 The Trump Organization is suing Capital One for de-banking its accounts in 2021, according to Eric Trump. The lawsuit was filed in Miami-Dade Circuit Court and claimed that …See details»